Shogi King Sota Fujii Makes Record Earnings from Winnings, Fees in 2023; 1st to Claim All 8 Shogi Titles in Year

Sota Fujii
13:45 JST, February 6, 2024
Multi-titleholder Sota Fujii earned a record ¥186.34 million from shogi prize money and playing fees in 2023, according to a list of the 10 highest-earning shogi players released by the Japan Shogi Association on Monday.
Fujii, 21, has topped the list for the second year in a row. In 2023, he became the first player to hold all eight titles of Ryuo, Meijin, Oi, Eio, Oza, Kio, Osho and Kisei at the same time.
Ninth-dan Akira Watanabe, 39, was second on the list with ¥45.62 million in earnings, followed by ninth-dan Takuya Nagase, 31, with ¥35.09 million.
Fujii’s earnings in 2023 were the highest on record for a shogi player since 1989, when the association started publishing the list.
The previous record was held by ninth-dan Yoshiharu Habu, 53, who earned ¥165.97 million in 1995. At the time, there were only seven titles, and Habu had nearly won them all.
At the beginning of 2023, Fujii held five of the titles, while Watanabe held the Kio and Meijin titles, and Nagase held the Oza title.
Fujii won the other three titles while defending his own, increasing his prize money and playing fees by ¥64.29 million compared to the previous year.
Top Articles in Society
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Bus Carrying 40 Passengers Catches Fire on Chuo Expressway; All Evacuate Safely
-
Tokyo Skytree’s Elevator Stops, Trapping 20 People; All Rescued (Update 1)
-
U.S. Firm to Build Training Hub in Fukushima N-plant for Debris Removal; Plans to Establish Training Center by 2029
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Videos Plagiarized, Reposted with False Subtitles Claiming ‘Ryukyu Belongs to China’; Anti-China False Information Also Posted in Japan
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

